Nanobiotix S.A. (EPA:NANO)
France · Delayed Price · Currency is EUR 28.85
+1.40 (5.10%)
Mar 13, 2026, 5:36 PM CET
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of €1.4 billion as of March 13, 2026. Its market cap has increased by 800.21% in one year.
Market Cap
1.40B
Enterprise Value
1.42B
Revenue
10.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
€28.85
Market Cap Chart
Since October 29, 2012, Nanobiotix's market cap has increased from 66.13M to 1.40B, an increase of 2,012.87%. That is a compound annual growth rate of 25.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.40B | 48.10% |
| Dec 31, 2025 | 943.39M | 558.09% |
| Dec 31, 2024 | 143.35M | -54.17% |
| Dec 29, 2023 | 312.82M | 147.96% |
| Dec 30, 2022 | 126.16M | -50.42% |
| Dec 31, 2021 | 254.47M | -46.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ABIVAX Société Anonyme | 7.50B |
| Inventiva | 1.02B |
| DBV Technologies | 982.17M |
| Valneva SE | 831.23M |
| MedinCell | 746.81M |
| Genfit | 433.47M |
| Cellectis | 243.74M |
| Transgene | 217.97M |